Fig. 5From: Antibodies against recombinant human alpha-glucosidase do not seem to affect clinical outcome in childhood onset Pompe diseaseInfusion associated reactions (IARs). a The number of patients with and without infusion associated reactions (IARs) across the three anti-recombinant human acid α-glucosidase (anti-rhGAA) antibody titer groups. b Correlation between the number of IARs and peak anti-rhGAA antibody titers (Spearman ρ = 0.234, p = 0.295)Back to article page